大博医疗
(002901)
| 流通市值：105.48亿 | | | 总市值：151.37亿 |
| 流通股本：2.89亿 | | | 总股本：4.14亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 992,975,831.66 | 1,075,945,032.18 | 1,011,928,158.97 | 993,830,861.47 |
| 应收票据及应收账款 | 274,960,293.37 | 235,579,112.44 | 265,370,017.42 | 267,839,605.62 |
| 其中：应收票据 | - | - | 200,000 | 400,000 |
| 应收账款 | 274,960,293.37 | 235,579,112.44 | 265,170,017.42 | 267,439,605.62 |
| 预付款项 | 30,002,921.5 | 31,892,255.64 | 55,244,229.6 | 41,613,776.77 |
| 其他应收款合计 | 18,244,055.73 | 9,873,538.4 | 12,011,460.75 | 11,757,325.61 |
| 存货 | 1,279,032,418.71 | 1,272,779,370.13 | 1,269,930,625.27 | 1,203,417,193.34 |
| 合同资产 | 91,200 | 91,200 | 108,300 | 108,300 |
| 其他流动资产 | 12,786,992.93 | 12,704,840.84 | 16,072,997.85 | 20,370,231.14 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,879,054,172.19 | 2,811,610,722.46 | 2,881,863,831.91 | 2,933,299,976.26 |
| 非流动资产: | | | | |
| 固定资产 | 1,080,280,523.66 | 1,101,179,566.26 | 1,056,687,512.11 | 1,067,447,996.68 |
| 在建工程 | 87,859,236.32 | 80,244,330.49 | 96,074,757.55 | 52,140,227.39 |
| 使用权资产 | 11,340,281.81 | 12,041,891.02 | 14,610,564.45 | 15,829,533.81 |
| 无形资产 | 122,649,208.05 | 125,606,740.86 | 127,626,089.63 | 130,692,111.53 |
| 商誉 | 67,643,622.61 | 67,773,367.45 | 67,914,231.34 | 67,618,296.31 |
| 长期待摊费用 | 198,635,606.93 | 203,095,673.43 | 202,542,676.25 | 203,316,347.65 |
| 递延所得税资产 | 15,680,655.33 | 14,425,311.06 | 11,368,424.01 | 10,761,965.84 |
| 其他非流动资产 | 3,003,000.38 | 2,952,000.38 | 2,144,029.94 | 1,930,020.93 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,587,092,135.09 | 1,607,318,880.95 | 1,578,968,285.28 | 1,549,736,500.14 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,466,146,307.28 | 4,418,929,603.41 | 4,460,832,117.19 | 4,483,036,476.4 |
| 流动负债: | | | | |
| 短期借款 | 80,084,022.46 | 80,056,663.87 | 72,050,138.87 | 122,088,772.74 |
| 应付票据及应付账款 | 230,735,204.91 | 253,321,886.53 | 257,671,103.88 | 290,142,371.62 |
| 应付账款 | 230,735,204.91 | 253,321,886.53 | 257,671,103.88 | 290,142,371.62 |
| 合同负债 | 117,834,641.8 | 118,953,318.06 | 131,809,489.21 | 138,198,594.14 |
| 应付职工薪酬 | 75,902,815.58 | 132,213,277.99 | 107,552,954.43 | 85,139,597.66 |
| 应交税费 | 39,850,558.44 | 47,046,362.74 | 33,482,993.53 | 20,640,822.45 |
| 其他应付款合计 | 240,568,466.95 | 238,901,979.5 | 235,846,802.31 | 266,244,471.63 |
| 应付股利 | - | - | - | 38,860,480.22 |
| 一年内到期的非流动负债 | 97,693,090.66 | 56,642,626.07 | 59,192,900.85 | 56,379,620.41 |
| 其他流动负债 | 13,882,770.21 | 14,261,727.64 | 15,395,114.65 | 16,768,825.12 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 896,551,571.01 | 941,397,842.4 | 913,001,497.73 | 995,603,075.77 |
| 非流动负债: | | | | |
| 长期借款 | 207,538,241.1 | 243,666,465.1 | 232,478,101.83 | 221,894,663.83 |
| 租赁负债 | 4,624,991.97 | 4,627,620.69 | 7,926,615.98 | 8,004,248.86 |
| 递延收益 | 48,874,307.31 | 45,510,764.52 | 46,671,221.31 | 48,788,238.32 |
| 递延所得税负债 | 1,832,619.47 | 2,114,965.18 | 2,365,473.97 | 1,763,869.61 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 262,870,159.85 | 295,919,815.49 | 289,441,413.09 | 280,451,020.62 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,159,421,730.86 | 1,237,317,657.89 | 1,202,442,910.82 | 1,276,054,096.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 414,019,506 | 414,019,506 | 414,019,506 | 414,019,506 |
| 资本公积 | 1,115,679,139.13 | 1,104,076,312.46 | 1,096,470,388.45 | 1,100,278,291.07 |
| 减:库存股 | 234,979,899.03 | 234,979,899.03 | 25,312,613.12 | - |
| 其他综合收益 | -4,146,250.78 | -4,310,111.55 | -5,242,399.78 | -5,159,205.96 |
| 盈余公积 | 271,042,124.11 | 271,042,124.11 | 271,042,124.11 | 271,042,124.11 |
| 未分配利润 | 1,632,242,746.11 | 1,529,141,179.64 | 1,412,213,717.81 | 1,310,581,739.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,193,857,365.54 | 3,078,989,111.63 | 3,163,190,723.47 | 3,090,762,454.84 |
| 少数股东权益 | 112,867,210.88 | 102,622,833.89 | 95,198,482.9 | 116,219,925.17 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,306,724,576.42 | 3,181,611,945.52 | 3,258,389,206.37 | 3,206,982,380.01 |
| 负债和股东权益合计 | 4,466,146,307.28 | 4,418,929,603.41 | 4,460,832,117.19 | 4,483,036,476.4 |
| 公告日期 | 2025-04-30 | 2025-04-24 | 2024-10-31 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |